| STABLE COMPOSITION OF AN ANABOLIC BONE PROTEIN WHICH IS AN ANALOG OF PTHRP, AND … |
2023-6-05 |
2023-7-21 |
|
| Methods for detecting neutralizing antibodies to parathyroid hormone (pth) and … |
2023-5-05 |
2023-8-31 |
|
| Abaloparatide formulations and methods of testing, storing, modifying, and … |
2023-3-22 |
2023-9-07 |
|
| FORMULATIONS OF PTHrP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF |
2022-11-04 |
2023-9-07 |
|
| Abaloparatide formulations and methods of testing, storing, modifying, and … |
2022-10-21 |
2023-2-23 |
|
| FORMULATIONS OF PTHrP ANALOGUE, TRANSDERMAL PATCH THEREOF, AND USE THEREOF |
2022-9-20 |
2022-11-22 |
|
| Formulations of Abaloparatide, Transdermal Patches Thereof, and Uses Thereof |
2022-9-07 |
2022-11-11 |
|
| Methods of treating a cardiovascular ischemic event |
2022-7-07 |
2023-1-12 |
|
| Treatment and prevention of osteoporosis in high body mass index individuals |
2022-5-25 |
2022-12-01 |
|
| USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK |
2022-3-25 |
2022-5-18 |
|
| Methods of improving spinal fusion with abaloparatide |
2022-3-11 |
2022-6-23 |
|
| Treatment of long bone fractures with abaloparatide |
2022-1-04 |
2023-7-13 |
|
| Transdermal system for the delivery of abaloparatide and method of use for … |
2021-8-06 |
2021-12-09 |
|
| Methods of stimulating bone growth with abalopartide and denosumab |
2021-1-22 |
2021-7-29 |
|
| Method of treating osteoporosis comprising administration of PTHrP analog |
2020-12-24 |
2023-3-07 |
2023-3-07 |
| METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES |
2020-8-31 |
2021-2-25 |
|
| Method of treating cancer using selective estrogen receptor modulators |
2020-8-06 |
2020-11-26 |
|
| Methods for treating cancer |
2020-8-04 |
2020-11-26 |
|
| Estrogen receptor-modulating compounds |
2020-7-21 |
2022-9-08 |
|
| Polymorphic forms of RAD1901-2HCL |
2020-7-06 |
2021-10-19 |
2021-10-19 |
| Self-emulsifying cannabidiol formulations |
2020-5-14 |
2020-11-19 |
|
| Cannabidiol nanocrystal compositions |
2020-5-14 |
2020-12-03 |
|
| Methods of Manufacturing Cannabidiol or Cannabidivarin and Intermediates of … |
2020-5-08 |
2020-11-12 |
|
| Processes and compounds |
2020-2-11 |
2022-5-26 |
|
| Methods for detecting neutralizing antibodies to parathyroid hormone (PTH) and … |
2020-1-10 |
2022-5-27 |
|
| Methods for treating cancer in models harboring esr1 mutations |
2019-12-06 |
2022-1-20 |
|
| Methods of treating CDK4/6 inhibitor-resistant cancers |
2019-12-06 |
2021-7-23 |
|
| Elacestrant in combination with abemaciclib in women with breast cancer |
2019-11-26 |
2022-4-21 |
|
| Ar+ breast cancer treatment methods |
2019-11-26 |
2020-6-04 |
|
| Method of treating cancer using selective estrogen receptor modulators |
2019-8-23 |
2020-1-09 |
|
| Polymorphic forms of rad1901-2hcl |
2019-7-03 |
2021-9-02 |
|
| Methods for treating ovarian cancer |
2019-3-21 |
2023-4-01 |
|
| Estrogen receptor-modulating compounds |
2019-1-22 |
2022-7-12 |
2022-7-12 |
| Stable cannabinoid formulations |
2017-9-22 |
2018-2-01 |
|
| Stable cannabinoid formulations |
2017-4-27 |
2017-8-10 |
|
| Selective androgen receptor modulators |
2016-11-07 |
2017-5-04 |
|
| Stable cannabinoid formulations |
2016-8-31 |
2016-12-22 |
|
| THERAPEUTIC SCHEMES |
2016-8-09 |
2017-5-17 |
|
| Stable cannabinoid formulations |
2016-5-27 |
2016-9-22 |
|
| Stable cannabinoid formulations |
2015-7-31 |
2022-5-17 |
2022-5-17 |
| Selective androgen receptor modulators |
2015-7-22 |
2015-11-12 |
|
| Stable cannabinoid formulations |
2015-5-28 |
2022-1-18 |
2022-1-18 |
| Selective androgen receptor modulators |
2012-8-09 |
2014-1-14 |
2014-1-14 |
| Method of drug delivery for PTH, PTHrP and related peptides |
2012-4-20 |
2013-12-12 |
|
| Method of drug delivery for pth, pthrp and related peptides |
2012-4-20 |
2016-8-30 |
|
| Method of drug delivery for bone anabolic protein |
2012-4-03 |
2014-6-10 |
2014-6-10 |
| Method of drug delivery for bone anabolic protein |
2012-3-13 |
2013-8-22 |
2013-8-22 |
| Selective Androgen Receptor Modulators |
2011-7-01 |
2012-1-05 |
|
| Selective Estrogen Receptor Modulator |
2011-3-15 |
2012-1-05 |
|
| Selective androgen receptor modulators |
2010-8-17 |
2013-6-04 |
2013-6-04 |
| Selective androgen receptor modulators |
2010-4-09 |
2010-10-14 |
|
| Estrogen receptor ligands |
2009-9-10 |
2010-3-18 |
|
| Combination therapy for breastcancer comprising an antiestrogenic agent |
2009-5-07 |
2009-11-12 |
|
| Treatment of vasomotor symptoms with selective estrogen receptor modulators |
2007-6-22 |
2009-3-25 |
|